111 related articles for article (PubMed ID: 21346391)
1. Experimental osteoarthritis in rats is attenuated by ABC294640, a selective inhibitor of sphingosine kinase-2.
Fitzpatrick LR; Green C; Maines LW; Smith CD
Pharmacology; 2011; 87(3-4):135-43. PubMed ID: 21346391
[TBL] [Abstract][Full Text] [Related]
2. Targeting ovarian cancer and chemoresistance through selective inhibition of sphingosine kinase-2 with ABC294640.
White MD; Chan L; Antoon JW; Beckman BS
Anticancer Res; 2013 Sep; 33(9):3573-9. PubMed ID: 24023282
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2.
French KJ; Zhuang Y; Maines LW; Gao P; Wang W; Beljanski V; Upson JJ; Green CL; Keller SN; Smith CD
J Pharmacol Exp Ther; 2010 Apr; 333(1):129-39. PubMed ID: 20061445
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of arthritis in rodents by a novel orally-available inhibitor of sphingosine kinase.
Fitzpatrick LR; Green C; Frauenhoffer EE; French KJ; Zhuang Y; Maines LW; Upson JJ; Paul E; Donahue H; Mosher TJ; Smith CD
Inflammopharmacology; 2011 Apr; 19(2):75-87. PubMed ID: 20936538
[TBL] [Abstract][Full Text] [Related]
5. The Sphingosine Kinase 2 Inhibitor ABC294640 Reduces the Growth of Prostate Cancer Cells and Results in Accumulation of Dihydroceramides In Vitro and In Vivo.
Venant H; Rahmaniyan M; Jones EE; Lu P; Lilly MB; Garrett-Mayer E; Drake RR; Kraveka JM; Smith CD; Voelkel-Johnson C
Mol Cancer Ther; 2015 Dec; 14(12):2744-52. PubMed ID: 26494858
[TBL] [Abstract][Full Text] [Related]
6. Targeting sphingosine kinase 2 by ABC294640 inhibits human skin squamous cell carcinoma cell growth.
Zhou J; Chen J; Yu H
Biochem Biophys Res Commun; 2018 Mar; 497(2):535-542. PubMed ID: 29428730
[TBL] [Abstract][Full Text] [Related]
7. ABC294640, A Novel Sphingosine Kinase 2 Inhibitor, Induces Oncogenic Virus-Infected Cell Autophagic Death and Represses Tumor Growth.
Dai L; Bai A; Smith CD; Rodriguez PC; Yu F; Qin Z
Mol Cancer Ther; 2017 Dec; 16(12):2724-2734. PubMed ID: 28939554
[TBL] [Abstract][Full Text] [Related]
8. Induction of an antiinflammatory effect and prevention of cartilage damage in rat knee osteoarthritis by CF101 treatment.
Bar-Yehuda S; Rath-Wolfson L; Del Valle L; Ochaion A; Cohen S; Patoka R; Zozulya G; Barer F; Atar E; Piña-Oviedo S; Perez-Liz G; Castel D; Fishman P
Arthritis Rheum; 2009 Oct; 60(10):3061-71. PubMed ID: 19790055
[TBL] [Abstract][Full Text] [Related]
9. A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors.
Britten CD; Garrett-Mayer E; Chin SH; Shirai K; Ogretmen B; Bentz TA; Brisendine A; Anderton K; Cusack SL; Maines LW; Zhuang Y; Smith CD; Thomas MB
Clin Cancer Res; 2017 Aug; 23(16):4642-4650. PubMed ID: 28420720
[No Abstract] [Full Text] [Related]
10. Sphingosine kinase inhibition exerts both pro- and anti-atherogenic effects in low-density lipoprotein receptor-deficient (LDL-R(-/-)) mice.
Poti F; Bot M; Costa S; Bergonzini V; Maines L; Varga G; Freise H; Robenek H; Simoni M; Nofer JR
Thromb Haemost; 2012 Mar; 107(3):552-61. PubMed ID: 22234485
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn's disease.
Maines LW; Fitzpatrick LR; Green CL; Zhuang Y; Smith CD
Inflammopharmacology; 2010 Apr; 18(2):73-85. PubMed ID: 20151210
[TBL] [Abstract][Full Text] [Related]
12. A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models.
Baragi VM; Becher G; Bendele AM; Biesinger R; Bluhm H; Boer J; Deng H; Dodd R; Essers M; Feuerstein T; Gallagher BM; Gege C; Hochgürtel M; Hofmann M; Jaworski A; Jin L; Kiely A; Korniski B; Kroth H; Nix D; Nolte B; Piecha D; Powers TS; Richter F; Schneider M; Steeneck C; Sucholeiki I; Taveras A; Timmermann A; Van Veldhuizen J; Weik J; Wu X; Xia B
Arthritis Rheum; 2009 Jul; 60(7):2008-18. PubMed ID: 19565489
[TBL] [Abstract][Full Text] [Related]
13. Suppression of colitis-driven colon cancer in mice by a novel small molecule inhibitor of sphingosine kinase.
Chumanevich AA; Poudyal D; Cui X; Davis T; Wood PA; Smith CD; Hofseth LJ
Carcinogenesis; 2010 Oct; 31(10):1787-93. PubMed ID: 20688834
[TBL] [Abstract][Full Text] [Related]
14. The monosodium iodoacetate model of osteoarthritis pain in the rat.
Marker CL; Pomonis JD
Methods Mol Biol; 2012; 851():239-48. PubMed ID: 22351096
[TBL] [Abstract][Full Text] [Related]
15. The monosodium iodoacetate model of osteoarthritis: a model of chronic nociceptive pain in rats?
Combe R; Bramwell S; Field MJ
Neurosci Lett; 2004 Nov; 370(2-3):236-40. PubMed ID: 15488329
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of sphingosine kinase-2 suppresses inflammation and attenuates graft injury after liver transplantation in rats.
Liu Q; Rehman H; Shi Y; Krishnasamy Y; Lemasters JJ; Smith CD; Zhong Z
PLoS One; 2012; 7(7):e41834. PubMed ID: 22848628
[TBL] [Abstract][Full Text] [Related]
17. Targeting NFĸB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2.
Antoon JW; White MD; Slaughter EM; Driver JL; Khalili HS; Elliott S; Smith CD; Burow ME; Beckman BS
Cancer Biol Ther; 2011 Apr; 11(7):678-89. PubMed ID: 21307639
[TBL] [Abstract][Full Text] [Related]
18. Effect of alcoholic extract of Entada pursaetha DC on monosodium iodoacetate-induced osteoarthritis pain in rats.
Kumari RR; More AS; Gupta G; Lingaraju MC; Balaganur V; Kumar P; Kumar D; Sharma AK; Mishra SK; Tandan SK
Indian J Med Res; 2015 Apr; 141(4):454-62. PubMed ID: 26112847
[TBL] [Abstract][Full Text] [Related]
19. A novel sphingosine kinase inhibitor induces autophagy in tumor cells.
Beljanski V; Knaak C; Smith CD
J Pharmacol Exp Ther; 2010 May; 333(2):454-64. PubMed ID: 20179157
[TBL] [Abstract][Full Text] [Related]
20. Pre-treatment with capsaicin in a rat osteoarthritis model reduces the symptoms of pain and bone damage induced by monosodium iodoacetate.
Kalff KM; El Mouedden M; van Egmond J; Veening J; Joosten L; Scheffer GJ; Meert T; Vissers K
Eur J Pharmacol; 2010 Sep; 641(2-3):108-13. PubMed ID: 20538089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]